Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry - Ding WY; Fawzy AM; Romiti GF; Proietti M; Pastori D; Huisman MV; Lip GYH; Abban DW; Abdul N; Abud AM; Adams F; Addala S; et al. (JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024)